Intra-arterial chemotherapy with gemcitabine and cisplatin for patients with recurrence of transitional cell carcinoma confined to the pelvis

Journal of Chemotherapy

Volumn 21, Issue 1, 2009, Pages 91-97

  Zhou, Fang J ^a   Yu, Shao L ^a   Li, Yong H ^a   Liu, Zhuo W ^a   Xiong, Yong H ^a   Wu, Pei H ^a   Han, Hui ^a   Qin, Zi K ^a  

^a SUN YAT SEN UNIVERSITY   (China)

Author keywords

Bladder; Chemotherapy; Cystectomy; Intra arterial chemotherapy; Transitional cell carcinoma

Indexed keywords

CISPLATIN; GEMCITABINE;

ADULT; AGED; ANEMIA; ARTICLE; BONE METASTASIS; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURGERY; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYSTECTOMY; DISEASE COURSE; DISEASE FREE SURVIVAL; DRUG EFFICACY; DRUG TOLERABILITY; ERYTHROCYTE TRANSFUSION; FEMALE; GASTROINTESTINAL SYMPTOM; HUMAN; KIDNEY PELVIS CARCINOMA; LIMB PAIN; MALE; MULTIPLE CYCLE TREATMENT; NAUSEA; NEUTROPENIA; PERIPHERAL EDEMA; SURVIVAL TIME; THROMBOCYTOPENIA; TRANSITIONAL CELL CARCINOMA; TREATMENT DURATION; TREATMENT RESPONSE; VOMITING;

EID: 63049108572     PISSN: 1120009X     EISSN: None     Source Type: Journal    
DOI: 10.1179/joc.2009.21.1.91     Document Type: Article

References (21)

1. Eapen L, Stewart D, Collins J. Effective bladder sparing therapy with intra-arterial cisplatin and radiotherapy for localized bladder cancer. J Urol 2004:172(4):1276-80
2. Mokarin A, Uetani M, Hayashi N, et al. Combined intraarterial chemotherapy and radiotherapy in treatment of bladder carcinoma. Cancer 1997: 80(9): 1776-85
3. Mokarin A, Uetani M, Sakamoto I, et al. Transarterial infusion of cisplatin and doxorubicin in bladder cancer. Acta Oncol 1997: 36(2):175-81
4. Hassan JM, Cookson MS, Smith JA. Pattern of initial transitional cell recurrence in patients after cystectomy. J Urol 2006:175(6): 2054-7
5. Stein JP, Lieskowsky G, Cote R, et al. Radical cystectomy in treatment of invasive bladder cancer: long-term results in 1054 patients. J Clin Oncol 2001: 19(3):666-75
6. Therasse P, Arbuck SG, Eisenhauer EA, et al. New guidelines to evaluate response to treatment in solid tumors. J Natl Cancer Inst 2000:92(3):205-16
7. Zhou FJ, Liu ZW, Yu SL, et al. Modified total cystectomy and neobladder: experience with 96 cases of invasive bladder cancer. Chin J Urol 2006: 27(8):549-51
8. Madersbacher S, Hochreiter W, Burkhard F, et al. Radical cystectomy for bladder cancer today - a homogeneous series without neoadjuvant therapy. J Clin Oncol 2003:21(4):690-6
9. von der Maase H, Hansen SW, Roberts JT, et al. Gemcitabine and cisplatin versus methotrexate, vinblastine, doxorubicin, and cisplatin in advanced or metastatic bladder cancer: results of a large, randomized, multinational, multicenter, phase III study. J Clin Oncol 2000:18(17):3068-77
10. von der Maase H, Sengelov L, Roberts JT, et al. Long-term survival results of a randomized trial comparing gemcitabine plus cisplatin, with methotrexate, vinblastine, doxorubicin, plus cisplatin in patients with bladder cancer. J Clin Oncol 2005:23(21):4602-8
11. Bajorin DF, Dodd PM, Mazumdar M, et al. Long-term survival in metastatic transitional-cell carcinoma and prognostic factors predicting outcome of therapy.J Clin Oncol 1999:17(10): 3173-81
12. Hoshi S, Mao H, Takahashi T, et al. Internal iliac arterial infusion chemotherapy for rabbit invasive bladder cancer. Int J Urol 1997: 4(5):493-9
13. Daniels JR, Sternlicht M, Daniels AM. Collagen chemoembolization: pharmacokinetics and tissue tolerance of cis-diamminedichloroplatinum(II) in porcine liver and rabbit kidney.Cancer Res. 1988:48(9):2446-50
14. Harima K, Harima Y, Hasegawa T, Tanaka Y. Transcatheter arterial embolization as a method of cisplatin-retention enhancement on the VX2 tumor uterus transplants. Cardiovasc Intervent Radiol. 1995: 18(1):30-4
15. Stewart DJ, Benjamin RS, Zimmerman S, et al. Clinical pharmacology of intraarterial cis-diamminedichloroplatinum(II). cancer Res 1983:43(February):917-20
16. Mantadaks E, Panagiotidis C, Delakas D, et al. Symptomatic relief of patients with advanced bladder carcinoma after regional intra-arterial chemotherapy. Anticancer Research, 2003:23(60): 5143-7
17. Stewart DJ, Eapen L, Hirte WE, et al. Intra-arterial cisplatin for bladder cancer. J Urol 1987:138(2):302-5
18. Tsukamoto S, Ishikawa S, Tsutsumi M, et al. An organ sparing treatment using combined intra-arterial chemotherapy and radiotherapy for muscle-invasive bladder carcinoma. Scand J Urol Nephrol 2002: 36(3):339-43
19. Siefker-radtke AO, Walsh GL, Pisters LL, et al. Is there a role for surgery in the management of metastatic urothelial cancer? The M.D. Anderson experience. J Urol 2004:171(1):145-8
20. Herr HW, Donat SM, Bajorin DF. Post-chemotherapy surgery in patients with unresectable or regionally metastatic bladder cancer. J Urol 2001:165(3):81-4
21. Sweeney P, Millikan R, Donat M, et al. Is there a therapeutic role for post-chemotherapy retroperitoneal lymph node dissection in metastatic transitional cell carcinoma of the bladder? J Urol 2003: 169(6): 2113-7